Searched for
ZOSYN
Being tactical not an option, but a necessity: Prescription for war and volatility; 7 pharma stocks with upside potential of up to 39%- Nothing wrong in being bullish, if you know why & what you are doing: 7 large-cap stocks with an upside potential of 2 to 20%
- They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%
- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...20 Feb, 2025, 06.11 PM IST
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...03 Dec, 2024, 04.06 PM IST
- Why predict time and magnitude of correction, focus on business and diversification: 6 large-cap stocks with upside potential of up to 38%After a long time, probably after March 2024, stock prices and the indices have corrected in a very sharp manner – and across the board. Th...06 Oct, 2024, 07.53 AM IST
- For investors with risk appetite; 5 mid cap stocks with right RoE and upside potential of up to 25%Earning seasons not only helps in judging what is happening to individual companies but more importantly it helps gauge the undercurrent of...21 Oct, 2023, 02.25 PM IST
- For risk takers: 5 midcap stocks from different sectors with right RoE and upside potential of up to 30%When valuations are high and sentiments are bullish and earning season is very close, it would be better to add the words like portfolio re...24 Sep, 2023, 12.48 PM IST
- For risk takers; 5 midcap stocks from different sectors with right levels of RoE and upside potential of up to 32%Last week, mid-cap stocks saw a sharp correction, because there was no major follow up selling, making the overall trend stay in the bullis...17 Sep, 2023, 12.42 PM IST
- Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started ro...12 Sep, 2023, 02.36 PM IST
- Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...09 Sep, 2023, 02.44 PM IST
- Will MNC pharma stocks get back their mojo for good or is it just a blip?Most of the MNC pharma companies have formed their subsidiary and a large majority of new drugs launched in India were via this route. This...23 May, 2023, 02.10 PM IST
- Pfizer recalls three anti-bacterial injections in India manufactured by Astral SteriTechThe company was informed by its contract manufacturer in India, Astral, that it has observed an out-of-specification during a routine envir...18 May, 2023, 10.51 PM IST
- Pfizer suspends sale & use of some popular products in India due to technical issuesIn a letter written to stockists, distributors and hospitals across India, Pfizer has asked for temporary suspension of sale and distributi...18 May, 2023, 04.10 PM IST
- Long term investing: 6 midcap stocks with high ROE & consistent ROCENothing wrong in getting excited about Nifty moving up, but before one buys they should be clear what they are buying and why they are buyi...09 Apr, 2023, 11.15 AM IST
- Long-term wealth creators: 6 midcaps with high ROE & net profit marginAs the Nifty stays in a volatile yet range-bound mode, besides fear of further correction, many investors, especially the ones sitting on c...19 Feb, 2023, 09.11 AM IST
- High ROE & net profit margin, 4 stocks with two key elements of long term wealth creatorsThere are some businesses which require a constant dose of capital and banking is one of them. There are some which may require a higher am...08 Jan, 2023, 12.24 PM IST
- Fifteen stocks in focus on Wednesday, 22 March 2017State-owned United Bank of India has set Rs 24.44 as the floor price for its Rs 1,500 crore QIP programme.22 Mar, 2017, 08.39 AM IST
- Wockhardt gets USFDA nod for generic anti-bacterial drugThe application for the product to the US Food and Drug Administration (USFDA) was made by the company's subsidiary Wockhardt Bio AG, the M...21 Mar, 2017, 07.16 PM IST
- 3 cos sue Wyeth over Zosyn patentThree generic pharmaceutical companies, including one from India, have taken legal action against US pharma major Wyeth.03 Feb, 2007, 02.57 AM IST
Load More
